Ruiz-Cobo, J. C., García-Samaniego Rey, F. J., Castellote, J., & Calleja Panero, J. L. (2024). Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.
Citación estilo ChicagoRuiz-Cobo, Juan Carlos, Francisco Javier García-Samaniego Rey, José Castellote, y José Luis Calleja Panero. Real-life Effectiveness of Sofosbuvir/velpatasvir/voxilaprevir in Hepatitis C Patients Previously Treated With Sofosbuvir/velpatasvir or Glecaprevir/pibrentasvir. 2024.
Cita MLARuiz-Cobo, Juan Carlos, Francisco Javier García-Samaniego Rey, José Castellote, y José Luis Calleja Panero. Real-life Effectiveness of Sofosbuvir/velpatasvir/voxilaprevir in Hepatitis C Patients Previously Treated With Sofosbuvir/velpatasvir or Glecaprevir/pibrentasvir. 2024.